Intuitive Surgical (NASDAQ: ISRG) promotes Taylor Patton to Chief Commercial and Marketing Officer

Rhea-AI Filing Summary

Intuitive Surgical, Inc. has announced an internal leadership change in its commercial organization. Taylor Patton, currently Global Senior Vice President of the company’s endoluminal business, will become Chief Commercial and Marketing Officer effective July 1, 2026 and join the Executive Leadership team.

Current Chief Commercial and Marketing Officer Henry L. Charlton will transition to Senior Vice President of Global Business Operations on the same date. The company highlights Patton’s nearly two decades of experience across its da Vinci, Ion and Digital platforms and notes that Charlton will work closely with Patton to support a smooth transition in global commercial and customer-support activities.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Effective date of leadership changes: July 1, 2026 Patients served: over 20 million patients

2 metrics

Effective date of leadership changes July 1, 2026 Date Taylor Patton becomes Chief Commercial and Marketing Officer

Patients served over 20 million patients Physicians enabled by Intuitive technologies have served this many patients

Key Terms

Chief Commercial and Marketing Officer, endoluminal business, Ion platform, Quintuple Aim

4 terms

Chief Commercial and Marketing Officer financial

"Taylor Patton to Chief Commercial and Marketing Officer, effective July 1."

endoluminal business technical

"Global Senior Vice President of Intuitive’s endoluminal business Taylor Patton"

Ion platform technical

"he led the worldwide launch and growth of Intuitive's Ion platform"

Quintuple Aim medical

"helping them achieve the Quintuple Aim across every platform, in every geography."

Understanding 8-K Material Events →

0001035267false00010352672026-05-282026-05-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported): May 28, 2026

INTUITIVE SURGICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-30713

77-0416458

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1020 Kifer Road

Sunnyvale, California 94086

(Address of Principal Executive Offices) (Zip Code)

   Registrant’s telephone number, including area code: (408) 523-2100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

ISRG

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨  

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer. A copy of the Company’s press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.						Description.
99.1						Press release issued by Intuitive Surgical, Inc., dated May 28, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INTUITIVE SURGICAL, INC.

Date: May 28, 2026

By:

/s/ JAMIE E. SAMATH

Jamie E. Samath

Executive Vice President and Chief Financial Officer

Exhibit 99.1

Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton

Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations

SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of Global Senior Vice President of Intuitive’s endoluminal business Taylor Patton to Chief Commercial and Marketing Officer, effective July 1.

Patton will join Intuitive’s Executive Leadership team and succeed Henry Charlton, who will assume the role of Senior Vice President of Global Business Operations. Charlton will work closely with Patton to support a smooth transition advancing Intuitive’s global impact and excellence in support of customers and their work to expand access to minimally invasive care.

Patton’s deep experience across Intuitive’s da Vinci, Ion and Digital platforms will maximize opportunities for consistent and world-class customer support while scaling commercial operations to meet the demands of continued global growth.

"Taylor has spent nearly two decades with Intuitive, building and scaling teams across multiple business units and geographies," said Intuitive CEO Dave Rosa. "He is uniquely positioned to lead at this moment in Intuitive's journey – having demonstrated the ability to launch new technologies, build new commercial organizations, and earn trust with customers around the world.”

"We are grateful for Henry’s outstanding leadership and contributions, which have been instrumental in establishing Intuitive as a global healthcare leader that has enabled physicians to serve over 20 million patients," continued Rosa. “In his new position, Henry will focus on Intuitive’s role in generating value for patients, physicians, and health care systems globally, and ensuring our customers receive world-class support no matter where they are.”

Patton has held leadership positions at Intuitive spanning commercial, marketing, and clinical application engineering. As global senior vice president of Intuitive’s endoluminal business, he led the worldwide launch and growth of Intuitive's Ion platform, a complex, multi-geography initiative that required building new commercial organizations, establishing clinical programs, and introducing a differentiated technology to diverse healthcare systems around the world.

"We are at a pivotal time in our journey to provide better care to patients, and I am fully committed to building on the exceptional foundation that Henry and our commercial teams have worked hard to create," said Patton. "Our customers are focused on delivering meaningful and differentiated outcomes for their patients and reducing the total cost to treat. Our goal is to provide customers the tools, support, training, and resources they need to succeed – ultimately helping them achieve the Quintuple Aim across every platform, in every geography."

"It has been a privilege to be a part of Intuitive since 2003, and I am excited about the opportunity to contribute to our next chapter as we continue to transform the future of healthcare,” said Charlton.

Contact:

Media.inquiries@intusurg.com

408-523-8181 ext. 6934681

About Intuitive

Intuitive (NASDAQ: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

Page 1 of 1

FAQ

What leadership change did Intuitive Surgical (ISRG) announce in this 8-K?

Intuitive Surgical announced a senior commercial leadership transition. Taylor Patton will become Chief Commercial and Marketing Officer, while Henry Charlton will move to Senior Vice President of Global Business Operations, both effective July 1, 2026, to support continuity in global commercial activities.

Who is Taylor Patton and what is his new role at Intuitive Surgical (ISRG)?

Taylor Patton is Intuitive’s Global Senior Vice President of its endoluminal business. He has led the worldwide launch and growth of the Ion platform and will become Chief Commercial and Marketing Officer, joining the Executive Leadership team effective July 1, 2026.

What new position will Henry Charlton hold at Intuitive Surgical (ISRG)?

Henry Charlton will become Senior Vice President of Global Business Operations. He is the current Chief Commercial and Marketing Officer and will focus on generating value for patients, physicians, and healthcare systems globally while ensuring customers receive world-class support in his new role.

When do the Intuitive Surgical (ISRG) leadership changes become effective?

The leadership changes at Intuitive become effective July 1, 2026. On that date, Taylor Patton assumes the Chief Commercial and Marketing Officer role and Henry Charlton transitions to Senior Vice President of Global Business Operations, with both leaders working together to ensure a smooth handover.

What experience does Taylor Patton bring to his new role at Intuitive Surgical (ISRG)?

Taylor Patton has nearly two decades of experience at Intuitive. He has held leadership roles across commercial, marketing, and clinical application engineering and led the global launch of the Ion platform, building new commercial organizations and clinical programs across multiple geographies and healthcare systems.

How does Intuitive Surgical (ISRG) describe Henry Charlton’s contributions?

Intuitive credits Henry Charlton with outstanding leadership and contributions. The company notes his role in helping establish Intuitive as a global healthcare leader that has enabled physicians to serve over 20 million patients, and highlights his continued impact in global business operations.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 7.0 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.2 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.8 KB